Acrivon Therapeutics Inc’s filing revealed that its 10% Owner PERCEPTIVE ADVISORS LLC acquired Company’s shares for reported $20.0 million on Apr 11 ’24. In the deal valued at $8.50 per share,2,353,000 shares were bought. As a result of this transaction, PERCEPTIVE ADVISORS LLC now holds 5,360,858 shares worth roughly $44.12 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ladenburg Thalmann upgraded its Acrivon Therapeutics Inc [ACRV] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Ladenburg Thalmann’s analysts, who decreased its forecast for the stock in late April from “a Buy” to “a Neutral”. JMP Securities began covering ACRV with “Mkt outperform” recommendation on March 01, 2024.
Price Performance Review of ACRV
On Monday, Acrivon Therapeutics Inc [NASDAQ:ACRV] saw its stock fall -7.63% to $8.23. Over the last five days, the stock has gained 4.18%. Acrivon Therapeutics Inc shares have risen nearly 67.28% since the year began. Nevertheless, the stocks have fallen -25.11% over the past one year. While a 52-week high of $11.90 was reached on 04/09/24, a 52-week low of $3.19 was recorded on 02/13/24. SMA at 50 days reached $8.12, while 200 days put it at $6.65.
Levels Of Support And Resistance For ACRV Stock
The 24-hour chart illustrates a support level at 7.58, which if violated will result in even more drops to 6.93. On the upside, there is a resistance level at 9.44. A further resistance level may holdings at 10.65. The Relative Strength Index (RSI) on the 14-day chart is 47.52, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.00, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 80.08%. Stochastics %K at 43.29% indicates the stock is a holding.
How much short interest is there in Acrivon Therapeutics Inc?
A steep rise in short interest was recorded in Acrivon Therapeutics Inc stocks on 2024-08-30, dropping by 6135.0 shares to a total of 1.03 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-31 was 1.03 million shares. There was a decline of -0.6%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on October 05, 2023 when Maxim Group began covering the stock and recommended ‘”a Buy”‘ rating .
